LifeArc announces £5 million drug repurposing programme for motor neuron disease
Filter by:
  • All
  • News Releases
  • Articles & blogs
  • Ventures Funding
    • 2 June 2017

    Beta amyloid-targeted therapeutic antibody

    Project Aim To develop a humanised antibody that specifically targets toxic species of Aβ for Alzheimer’s Disease…